teaser
The future work of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) was discussed at a recent meeting in London.
The annual meeting of The Organisation for Professionals in Regulatory Affairs (TOPRA) took place in the EMA building in Canary Wharf from November 24
